Senior Data Scientist - AI Data Science at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Advanced knowledge in data & analytics and thorough knowledge of other functions, typically gained through a university degree and 4+ years of experience
Knowledge in data & analytics skillsets such as data provisioning, data mining, data visualization, machine learning, GenAI code development in Python/R, GitHub, cloud computing platforms like AWS, model governance with MLFlow or equivalent
Potential to lead initiatives related to implementation of new technologies, especially LLM-based solutions
Ability to package information and data that tells a story and provides insight to a broader problem; presents and explains implications of key information on issues important to the business unit
Frequent interaction with internal and external stakeholders regarding operational decisions and business requirements; analyzes impact of conclusions and actions on people, technology, structure, and workflow across teams
Gives others challenging opportunities to build strong capabilities for the team; helps drive a culture which motivates awareness and learning through creating space for conversations and debate
Demonstrates a focus on improving processes, structures, and knowledge within the team; leads in analyzing current states and delivering strong recommendations in understanding complexity in the environment
Stay up-to-date with emerging trends in data science and machine learning

Responsibilities

Develop and deliver AI-powered solutions that will bring more medicines to more patients faster
Develop ML pipelines that can evolve rapidly to incorporate new and/or more effective modeling approaches
Partner with business and IT groups to scale and operationalize AI solutions to advance business goals and gain competitive advantage
Engage a broader community to help educate the business on the practical application of AI to drive business value and widespread adoption
Serve as a knowledge expert in foundation models and communicate insights, recommendations, value and impact to technical and non-technical stakeholders

Skills

Data Science

Machine Learning

ML Pipelines

Artificial Intelligence

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free